Dyadic International is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mark A. Emalfarb, with a market cap of $27.5M.
Based on Q1 2026 filing
Common questions about Dyadic International
Dyadic International (DYAI) has a market capitalization of $27.5M and trades on NASDAQ.
Dyadic International has approximately 7 employees.